While NeuroOne Medical Tech reported a YoY decrease in losses, which is generally a positive sign, the company also reported a significant increase in sales. This could indicate that the company is making progress in its operations, which could potentially attract investors. However, the fact that the company is still reporting losses could also deter some investors. Therefore, the impact on the stock price could be neutral in the short term.